Back to YC Companies
Alixia
Winter 2022
Active
Targeting the Tumor Ecosystem to address cancer drug resistance.
2 people View on YC
Alixia at a glance
- Y Combinator batch
- Winter 2022
- Status
- Active
- Industry
- Healthcare
- Team size
- 2 people
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
About Alixia
Our compounds disrupt the metabolic and inflammatory triggers in both cancer and quasi-cancerous cells in the tumor microenvironment. By impacting multiple cell types, we are enabling effective, lasting cancer treatments.
Tags:
Biotech
Therapeutics
Drug discovery
Oncology
Biotechnology